glp 1 agonists oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies GLP-1 Agonists: A Comprehensive Overview

They include excess abdominal weight, high blood pressure, high blood sugar levels and high cholesterol

Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society

This can lead to daytime fatigue, headaches and other short-term symptoms, as well as an increased risk of cardiovascular disease, diabetes and mental health changes

European Journal of Clinical Investigation, 38 (10), 743751

Therefore, fatty acids are the preferred substrate for ATP production in a healthy heart

doi: 10.1016/j.humimm.2021.03.004 25 LiuYWuMXuBKangL